CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects

Fan Zhang1, Yuan Yang, Cheng Guo

  • 1Department of Maternal and Child Health, School of Public Health and Health Management, Chongqing Medical University, Chongqing 400016, China.

Mutagenesis
|April 20, 2012
PubMed

Insights

The CASP8 -652 6N del polymorphism is linked to a reduced risk of cancer. This genetic variation shows a protective effect, particularly in Asian and Caucasian populations and for colorectal cancer.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Apoptosis, regulated by caspases, is crucial in preventing cancer development.
  • The CASP8 gene encodes caspase-8, vital for T lymphocyte apoptosis.
  • Previous studies on the CASP8 -652 6N del polymorphism and cancer risk yielded inconsistent results.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between the CASP8 -652 6N del polymorphism and cancer risk.
  • To synthesize findings from multiple studies to overcome individual study limitations.

Main Methods:

  • A meta-analysis combining data from 30 case-control studies.
  • Inclusion of 23,700 cancer cases and 26,412 controls.
  • Analysis of allele contrast, additive, dominant, and recessive genetic models.

Main Results:

  • The CASP8 -652 6N del polymorphism was associated with a decreased overall cancer risk across various genetic models.
  • Stratified analyses revealed a significantly reduced risk for Asians and Caucasians.
  • A reduced risk was also observed in the colorectal cancer group and an 'other cancers' group.

Conclusions:

  • The CASP8 -652 6N del polymorphism is associated with a reduced risk of cancer.
  • This protective effect is particularly notable in Asian and Caucasian populations and for individuals with colorectal cancer.
  • Further research is recommended to explore additional ethnic groups and cancer types for a comprehensive understanding.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...